GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress
Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.
- Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.
- “At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare.
- At ESTRO 2024, GE HealthCare will also be showcasing the newly updated iRT platform, which was originally launched at ESTRO 2023.
- To learn more about GE HealthCare’s latest innovations within oncology care, please visit the ESTRO 2024 Congress booth #220 in Glasgow from May 3-7 or visit the website here .